Current Management of Acute Bronchiolitis in Incheon.
- Author:
Jung Sun KIM
1
;
Doo Kyo IN
;
Yong Han SUN
;
Hee Joo HONG
;
Kang Ho CHO
;
Dong Woo SON
;
In Sang JEON
;
Hann TCHAH
Author Information
1. Department of Pediatrics, Gachon Medical School, Incheon, Korea. pedsyh@gilhospital.com
- Publication Type:Original Article
- Keywords:
Bronchiolitis;
Management;
Pediatrician
- MeSH:
Bronchiolitis*;
Bronchodilator Agents;
Consensus;
Incheon*;
Inhalation;
Surveys and Questionnaires;
Respiratory Tract Infections;
Steroids;
Xanthines
- From:Pediatric Allergy and Respiratory Disease
2006;16(2):150-161
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Although acute bronchiolitis is the most common lower respiratory tract infection in the first year of life, the use of pharmaceutical agents has been debated. The purpose of this study was to examine the current management practice of acute bronchiolitis by pediatricians in Incheon and to compare this with management internationally. METHODS: We sent postal questionnaires to all pediatricians in Incheon to assess their current practice for treating acute bronchiolitis. We analyzed the frequency of bronchodilators, steroids, xanthines use. These results were compared with international management. RESULTS: Of a total 131 questionnaires, 80(61 percent) were returned. Ninety percent of pediatricians used bronchodilator inhalation, either routinely(41 percent) or occasionally(43 percent). Steroid were used by 93 percent of the respondents, always(23 percent) or sometimes (65 percent). Pediatricians in Incheon tended to use pharmaceutical agents more frequently than Australian pediatricians who have consensus guidelines for the management of acute bronchiolitis, and as frequently as Swiss pediatricians who do not. CONCLUSION: Pharmaceutical agents are frequently used in the management of acute bronchiolitis by pediatricians in Incheon. Better therapeutic approaches are needed for bronchiolitis care.
